GenMark Diagnostics Inc (GNMK)-医療機器分野:企業M&A・提携分析

◆英語タイトル:GenMark Diagnostics Inc (GNMK) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011699
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GenMark Diagnostics Inc (GenMark) is a medical device company that offers clinical testing systems. The company’s products comprise XT-8 systems and ePlex systems. Its pipeline products include eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test and others. GenMark develops products used in treatment of CNS infections, GI infections, genetic conditions, hepatitis, respiratory infections and sepsis. The company offers educational resources to medical professionals in the areas of cystic fibrosis, respiratory viral panel, thrombophilia and warfarin sensitivity. It operates in the US and Switzerland. GenMark is headquartered in Carlsbad, California, the US.

GenMark Diagnostics Inc (GNMK) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GenMark Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
GenMark Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
GenMark Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
GenMark Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
GenMark Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
GenMark Diagnostics Inc, Medical Equipment, Deal Details 10
Partnerships 10
PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 10
GenMark Diagnostics Enters Into Co-Development Agreement With Advanced Liquid Logic For Integrated Diagnostic Platform 11
Equity Offering 12
GenMark Diagnostics Prices Public Offering of Shares for USD75 Million 12
GenMark Diagnostics Completes Public Offering Of Shares For US$86.3 Million 14
GenMark Diagnostics Completes Public Offering Of Shares For US$48 Million 16
GenMark Diagnostics Completes Public Offering Of Common Stock For US$35 Million 18
GenMark Diagnostics Inc – Key Competitors 20
GenMark Diagnostics Inc – Key Employees 21
GenMark Diagnostics Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
Nov 02, 2017: GenMark Diagnostics Reports Third Quarter 2017 Results 23
Aug 01, 2017: GenMark Reports Second Quarter 2017 Results 24
May 02, 2017: GenMark Diagnostics Reports First Quarter 2017 Results 25
Feb 28, 2017: GenMark Diagnostics Reports Fourth Quarter and Full Year 2016 Results 26
Jan 10, 2017: GenMark Announces Preliminary Q4 2016 Financial Results 27
Nov 03, 2016: GenMark Diagnostics Reports Q3 Financial Results 28
Jul 28, 2016: GenMark Diagnostics Reports Q2 Financial Results 29
May 03, 2016: GenMark Reports First Quarter 2016 Results 30
Feb 23, 2016: GenMark Reports Fourth Quarter and Full Year 2015 Results 31
Jan 12, 2016: GenMark Announces Preliminary Q4 Financial Results and Initiation of ePlex Analytical Studies 32
Legal and Regulatory 33
Jun 29, 2017: GenMark Achieves CE Mark for its ePlex Blood Culture Identification Gram-Positive and Gram-Negative Panels 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
GenMark Diagnostics Inc, Medical Equipment, Key Facts, 2016 2
GenMark Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
GenMark Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
GenMark Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
GenMark Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
GenMark Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
GenMark Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 10
GenMark Diagnostics Enters Into Co-Development Agreement With Advanced Liquid Logic For Integrated Diagnostic Platform 11
GenMark Diagnostics Prices Public Offering of Shares for USD75 Million 12
GenMark Diagnostics Completes Public Offering Of Shares For US$86.3 Million 14
GenMark Diagnostics Completes Public Offering Of Shares For US$48 Million 16
GenMark Diagnostics Completes Public Offering Of Common Stock For US$35 Million 18
GenMark Diagnostics Inc, Key Competitors 20
GenMark Diagnostics Inc, Key Employees 21

★海外企業調査レポート[GenMark Diagnostics Inc (GNMK)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Synexus Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Synexus Ltd (Synexus), a subsidiary of Synexus Clinical Research Limited, is a site management organisation that offers patient recruitment and trial management services. The company services include feasibility assessment, project management, patient engagement, patient-centric clinical tri …
  • Super-Sol Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Super-Sol Limited Mergers and A …
  • Chromedx Corp. (CHX):企業財務及び戦略的SWOT分析
    Summary Chromedx Corp. (Chromedx), formerly known as Monarch Energy Limited is an medical technology company focused on the development of novel medical devices for in vitro diagnostics and point-of-care testing. The company provides two technologies based on granted and pending patents such as Hemo …
  • InnerWorkings, Inc.:企業の戦略・SWOT・財務分析
    SummaryInnerWorkings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • BR Malls Participacoes SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BR Malls Participacoes SA Merge …
  • JW Pharmaceutical Corporation (001060):企業概要、財務及び戦略的SWOT分析
    Summary JW Pharmaceutical Corporation (JW Pharmaceutical) is a pharmaceutical company. The company develops, produces and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, antifungal agents, cardiovascular agents, gastrointestinla agents, miscellan …
  • Baxter International Inc (BAX):企業のM&A・提携動向(医療分野)
    Summary Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products. It undertakes the development, manufacture and marketing of medical products, which assist healthcare professionals and their patients in the treatment of end-stage renal diseases. Its portfolio …
  • Umanis SA (ALUMS):企業の財務及び戦略的SWOT分析
    Summary Umanis SA (Umanis), formerly Europstat, is a technical service provider that provides consulting services. The company offers services in the areas such as advising, resale hardware and software, engineering, infrastructure and production, contract research organization and multi-channel con …
  • Fate Therapeutics, Inc. (FATE)(製薬・医療分野):企業M&A動向
    Summary Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. It focuses on the discovery and development of adult stem cell pharmacologic modulators for the patients with rare life threatening disorders. The company has developed two platforms, namely, HSC Modul …
  • Accurate Energetic Systems, LLC:企業の戦略・SWOT・財務分析
    SummaryAccurate Energetic Systems, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the comp …
  • McDonald’s Australia Limited:企業の戦略的SWOT分析
    McDonald's Australia Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Shop Direct Group Ltd : Retailing:企業概要およびSWOT分析
    Summary Canadean's "Shop Direct Group Ltd : Retailing - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company histor …
  • Sonatrach SPA:企業の戦略的SWOT分析
    Sonatrach SPA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Colgate-Palmolive Company:企業の戦略・SWOT・財務分析
    SummaryColgate-Palmolive Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • JTEKT Corporation (6473):企業概要、財務及び戦略的SWOT分析
    Summary JTEKT Corporation (JTEKT) is an equipment manufacturing company. The company manufactures and markets steering systems, electronic control devices, machine tools, home accessory equipment, bearings, and driveline components. Its products include electric power steering, hydraulic power steer …
  • OAO Mostotrest:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OAO Mostotrest Mergers and Acqu …
  • Luxi Chemical Group Co., Ltd. (000830):企業の財務及び戦略的SWOT分析
    Summary Luxi Chemical Group Co., Ltd. (Luxi Chemical) is a chemical company that offers coal chemical, salt chemical, fluorine and silicon chemical, and petrochemical. The company’s coal and petrochemical products include hydrogen peroxide, methanol, melamine, formic acid, caprolactam, nylon-6, cycl …
  • China Green Agriculture Inc. (CGA):企業財務及び戦略的SWOT分析
    Summary China Green Agriculture Inc. (CGA) is a chemical company that produces and distributes the humic acid liquid compound fertilizer. The company provides organic compound fertilizer, mixed organic-inorganic compound fertilizer and blended fertilizer. Its products include citrus nutrition, guang …
  • KBC Group NV:企業のM&A・提携・投資分析
    KBC Group NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KBC Group NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Kingold Jewelry, Inc. (KGJI):企業概要、財務及び戦略的SWOT分析
    Summary Kingold Jewelry, Inc. (Kingold) is a jewelry manufacturer. The company designs, manufactures and sells jewelry. Its products include gold necklaces, rings, earrings, bracelets, pendants, gifts and gold bars. Kingold sells products to wholesale and retail customers across China. The company s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆